Novel Carbon Dots Derived from Moutan Cortex Significantly Improve the Solubility and Bioavailability of Mangiferin
DOI: https://doi.org/10.2147/ijn.s456053
IF: 7.033
2024-04-21
International Journal of Nanomedicine
Abstract:Chuihao Kong, 1, 2, &ast Kaidi Wang, 1, 2, &ast Lei Sun, 1, 3 Hongsu Zhao, 1, 2 Tongsheng Wang, 1 Wuxi Zhou, 1 Deling Wu, 1, 2 Fengqing Xu 1, 2 1 School of Pharmacy, Anhui University of Chinese Medicine, Hefei, 230012, People's Republic of China; 2 Anhui Province Key Laboratory of New Manufacturing Technology for Traditional Chinese Medicine Decoction Pieces, Hefei, 230012, People's Republic of China; 3 Zhejiang CONBA Pharmaceutical Co. LTD, Hangzhou, 310052, People's Republic of China &astThese authors contributed equally to this work Correspondence: Wuxi Zhou; Fengqing Xu, School of Pharmacy, Anhui University of Chinese Medicine, 350 Longzihu Road, Xinzhan District, Hefei, 230012, People's Republic of China, Email ; Background: Mangiferin (MA), a bioactive C-glucosyl xanthone with a wide range of interesting therapeutic properties, has recently attracted considerable attention. However, its application in biomedicine is limited by poor solubility and bioavailability. Carbon dots (CDs), novel nanomaterials, have immense promise as carriers for improving the biopharmaceutical properties of active components because of their outstanding characteristics. Methods: In this study, a novel water-soluble carbon dot (MC-CDs) was prepared for the first time from an aqueous extract of Moutan Cortex Carbonisata , and characterized by various spectroscopies, zeta potential and high-resolution transmission electron microscopy (HRTEM). The toxicity effect was investigated using the CCK-8 assay in vitro. In addition, the potential of MC-CDs as carriers for improving the pharmacokinetic parameters was evaluated in vivo. Results: The results indicated that MC-CDs with a uniform spherical particle size of 1– 5 nm were successfully prepared, which significantly increased the solubility of MA in water. The MC-CDs exhibited low toxicity in HT-22 cells. Most importantly, the MC-CDs effectively affected the pharmacokinetic parameters of MA in normal rats. UPLC-MS analysis indicated that the area under the maximum blood concentration of MA from mangiferin-MC-CDs (MA-MC-CDs) was 1.6-fold higher than that from the MA suspension liquid (MA control) after oral administration at a dose of 20 mg/kg. Conclusion: Moutan Cortex -derived novel CDs exhibited superior performance in improving the solubility and bioavailability of MA. This study not only opens new possibilities for the future clinical application of MA but also provides evidence for the development of green biological carbon dots as a drug delivery system to improve the biopharmaceutical properties of insoluble drugs. Keywords: Moutan Cortex , carbon dots, mangiferin, solubility, bioavailability Graphical Mangiferin (MA), a natural C -glucosyl xanthone scaffold initially isolated from Mangifera indica , exhibits a wide range of interesting pharmacological activities, such as cardioprotective, immunomodulatory, antioxidant, antitumor, antidiabetic, and anti-inflammatory effects. 1–7 The therapeutic significance of MA has made it attractive for the research and development of drugs and food supplements over decades. Nonetheless, some limitations caused by the structural type of xanthone C -glycoside, including scarce solubility in water and low bioavailability, severely restrict its clinical applications. 8 Currently, several studies on solubilization methods have been conducted to improve the water solubility and bioavailability of MA, but there is still a lack of satisfactory outcome. 9–16 Therefore, developing new materials and techniques to improve MA's biopharmaceutical properties of MA is a challenging issue and requires a considerable amount of effort. The hydrophilicity and bioavailability of insoluble active components can be improved by making into nanomaterials which are a special class of materials with unique physical, chemical, and biological properties. 17–20 Many studies have aimed at developing novel nanomaterial-based sensors for applications in biology and medicine, while their clinical applications are greatly restricted by high cost and adding highly toxic components. 21–23 As novel nanomaterials, carbon dots (CDs) have gained particular attention in recent years owing to their outstanding characteristics and wide-ranging pharmaceutical applications. 24–38 In particular, their small size and large surface area make them highly water-soluble and biocompatible, which holds great promise for drug delivery. However, most CDs are chemically synt -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology